Do I Qualify for Ozempic?

You may be a candidate for Ozempic if a healthcare provider confirms that you fit its approved use and it's safe alongside your health history. In general, that means:

• You are an adult with type 2 diabetes and need better blood-sugar control, often when metformin or lifestyle changes alone aren't enough.
• You have type 2 diabetes and established heart disease, where Ozempic is also approved to reduce the risk of major cardiovascular events.
• You can use a weekly injectable and don't have conditions that make it unsafe (see below).

Understanding the label is the key to eligibility, because it drives both prescribing and insurance coverage.

Ozempic and Wegovy contain the same active ingredient (semaglutide) but are approved for different purposes. That's why someone focused on weight loss is usually steered toward Wegovy or Zepbound.

Because Ozempic is a diabetes drug, it has no BMI cutoff. BMI thresholds apply to the weight-management drugs:

• BMI ≥ 30 (obesity), or
• BMI ≥ 27 (overweight) plus a weight-related condition such as high blood pressure, high cholesterol, prediabetes, or sleep apnea.

For the on-label diabetes use, a provider typically looks for a confirmed type 2 diabetes diagnosis (via A1c or glucose testing) and considers where you are in treatment — for example, whether metformin or lifestyle changes have been tried. Ozempic is not approved for type 1 diabetes.

Even when you qualify medically, coverage is a separate hurdle. Plans usually cover Ozempic for diabetes but often deny it for weight loss, and nearly all require prior authorization.

Ozempic may not be appropriate — or may be unsafe — for people with certain conditions. Your clinician will screen for these:

• A personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• A history of pancreatitis or serious gallbladder disease (used with caution).
• Type 1 diabetes or diabetic ketoacidosis.
• Pregnancy or breastfeeding, or planning pregnancy soon.
• Severe gastrointestinal conditions such as gastroparesis.

• Given my diagnosis, is Ozempic the right GLP-1, or would Wegovy, Zepbound, or Mounjaro fit better?
• What are my risks based on my personal and family history?
• Will my insurance cover it, and can we prepare the prior authorization together?
• How will we titrate the dose and manage side effects?
• What diet, protein, and activity plan should go alongside it?

If Ozempic isn't the right fit, options a clinician might discuss include Wegovy or Zepbound (approved for weight), Mounjaro (diabetes), Rybelsus (an oral semaglutide for diabetes), or older options like liraglutide. The best choice depends on your goal, your health history, and coverage.